| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95eaed79dec59391549e8016815b3a8f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 |
| filingDate |
2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_482407ccfce9b2fcd53944a80320fc25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f87a9dba0a660de967cde44a7b99e20b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6f5de2edc594d986c2aa144bc448a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a47f1a5997f79f6e39ff919de78936c4 |
| publicationDate |
2008-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080016948-A |
| titleOfInvention |
Novel triterpenic acid derivatives and external preparations for skin containing the same |
| abstract |
By phosphorylating at least one hydroxyl group of triterpenic acid having a hydroxyl group to phosphorylated triterpenic acid and / or salts thereof, it improves solubility in the external preparation of the skin and sufficiently exerts the physiological activity of triterpenic acid. . As said phosphorylated triterpenic acid, ursolic acid phosphate ester and / or its salt can be illustrated preferably. As said external preparation for skin, cosmetics are preferable and pseudopharmaceuticals are especially preferable. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200065622-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101684432-B1 |
| priorityDate |
2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |